Targeting the“blood stasis”network:therapeutic strategies and molecular mechanisms of blood-activating traditional chinese medicines in the treatment of vascular dementiaOA
Vascular dementia(VaD)is primarily characterized by cerebral hypoperfusion,and currently,there is a lack of approved disease-modifying treatments,highlighting the urgent need for comprehensive intervention strategies targeting multiple pathways.Based on the traditional Chinese medicine(TCM)concept that“blood stasis”is a constant pathological mechanism throughout the disease course,this paper proposes and elucidates the“Blood Stasis Network”framework.We systematically summarize the research evidence and molecular mechanisms of blood-activating TCMs in treating VaD.Unlike the conventional neurovascular unit(NVU)framework or general multi-target pharmacological paradigms,the proposed“Blood Stasis Network”is conceptualized as a cross-scale pathological model that links TCM syndrome theory with sequential and mutually reinforcing mechanisms in VaD.It emphasizes not only the coexistence of multiple pathological events but also their hierarchical organization,causal feedback loops,and potential responsiveness to blood-activating interventions.The framework identifies cerebral microcirculation impairment and vascular endothelial dysfunction as key nodes of the network,inflammation and oxidative stress as pathological amplifiers,and emphasizes the role of blood-brain barrier(BBB)disruption and neurovascular uncoupling in the network stabilization and disease progression.Within this context,we delineate a hierarchical,synergistic intervention model encompassing single herbs,active bioactive components,and compound formulas.These interventions function through multi-modal pathways:restoring cerebral perfusion and endothelial homeostasis,mitigating oxidative and inflammatory stress,preserving BBB integrity and neurovascular coupling,and fostering synaptic plasticity and neuronal survival.We also discuss the value of the network pharmacology“prediction–validation–revision”loop in elucidating mechanisms and optimizing compound formulas.Overall,blood-activating TCMs hold the potential for multi-node coordinated regulation of the Blood Stasis Network.However,further translational applications require the construction of multi-omics biomarkers,integration of pharmacokinetics and pharmacodynamics,and high-quality clinical studies.
Qiu-Dong Zhang;Xing-Fang Zhang;Min Bai;Meng-Ye Zhang;Ji-Ping Yu;Ya-Jun Shi;Yi Ding
School of Pharmacy,Shaanxi University of Chinese Medicine,Xi’an 712046,China Department of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,ChinaSchool of Pharmacy,Shaanxi University of Chinese Medicine,Xi’an 712046,China Department of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,ChinaSchool of Pharmacy,Shaanxi University of Chinese Medicine,Xi’an 712046,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,China
医药卫生
vascular dementiablood stasis networkmolecular mechanismsmulti-target therapy
《Traditional Medicine Research》 2027 (1)
P.63-79,17
financially supported by the National Natural Science Foundation of China(82274313)Projects of Shaanxi Administration of Traditional Chinese Medicine(2022-SLRH-YQ-010)Key Laboratory of Pharmacology of Traditional Chinese Medicine.
评论